PB

Pushapa Baburao Sathe

Active Director Director DIN 10534328
DIN 10534328 First appointment Mar 2024 Primary industry Machinery and Equipment
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Pushapa Baburao Sathe

Data last updated:

Pushapa Baburao Sathe is a Director at Fabon Pharmatech Private Limited (since 2024). The company operates in Machinery and Equipment.

DIN 10534328
Primary Designation Director
Industry Machinery and Equipment
First Appointment 04 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Fabon Pharmatech Private Limited U32909MH2024PTC420626
Director04 Mar 20242024Active

Board colleagues of Pushapa Baburao Sathe

NameDINCompanyDesignation
Satish Dada Ghoderao08088304Fabon Pharmatech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Fabon Pharmatech Private Limited
Premium access

Shareholding and investment profile for Pushapa Baburao Sathe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pushapa Baburao Sathe

Pushapa Baburao Sathe currently holds 1 directorship: Fabon Pharmatech Private Limited (Director, since 04 Mar 2024).

Pushapa Baburao Sathe was first appointed on 04 Mar 2024 as Director at Fabon Pharmatech Private Limited.

The current boards of Pushapa Baburao Sathe's companies include Satish Dada Ghoderao (Fabon Pharmatech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available